Michel De Cleyn
Janssen (Belgium)(BE)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Alzheimer's disease research and treatments, Drug Transport and Resistance Mechanisms, Chemical Synthesis and Analysis, Click Chemistry and Applications
Most-Cited Works
- → 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads(2015)77 cited
- → Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators(2012)60 cited
- → Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads(2019)33 cited
- → JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical Candidate(2021)20 cited
- → Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate(2018)18 cited
- → Anilinotriazoles as potent gamma secretase modulators(2014)16 cited
- → A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo(2021)8 cited
- → Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators(2019)7 cited
- → Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic study(2021)5 cited
- → Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo Exploration(2025)4 cited